Literature DB >> 34790401

Diagnostic role of contrast-enhanced ultrasonography versus conventional B-mode ultrasonography in cirrhotic patients with early hepatocellular carcinoma: a retrospective study.

Yandong Jiang1, Meng Zhang1, Yanting Zhu1, Dongxiao Zhu1.   

Abstract

BACKGROUND: Early diagnosis of hepatocellular carcinoma (HCC) is very important for the prognosis of patients. However, there are very few studies that compared the diagnostic accuracy of contrast-enhanced ultrasonography (CEUS) and B-mode ultrasonography for early HCC in cirrhotic patients.
METHODS: This retrospective study included cirrhotic patients, who were suspected of early HCC between January 2020 and June 2021. The diagnosis of patients was based on the pathology results of surgery or biopsy. Demographic and clinical characteristics of included patients were recorded. The diagnoses of suspected lesions using both types of ultrasonography were recorded, and the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of early HCC in cirrhotic patients were calculated.
RESULTS: Eventually, 137 patients with solitary lesions in the liver were included in this study, including 89 patients diagnosed with HCC and 48 patients diagnosed with non-HCC. The median diameter of suspected lesions was 26 mm, and the median level of alpha fetoprotein (AFP) was 37.2 ng/mL. When comparing the demographic and clinical characteristics of cirrhotic patients with HCC and non-HCC, it was found that patients with HCC had significantly higher levels of AFP than those with non-HCC (P=0.03). The sensitivity, specificity, PPV, NPV, and accuracy of CEUS in early HCC were 73%, 93.8%, 95.6%, 65.2% and 80.3%, respectively. In CEUS, all of these parameters were much higher than those in B-mode ultrasonography, i.e., 64%, 75%, 82.6%, 52.9%, and 67.9%. It was also found that the diagnostic accuracy of CEUS was much higher than that of B-mode ultrasonography especially regarding lesions <20 mm. To further improve the sensitivity of CEUS in early HCC, AFP was combined with CEUS for the diagnosis of early HCC. As a result, the sensitivity, specificity, PPV, NPV, and accuracy of CEUS combined with AFP level were 83.1%, 87.5%, 92.5%, 73.7%, and 84.7%, respectively.
CONCLUSIONS: Our study confirmed that CEUS' diagnostic accuracy for early HCC in cirrhotic patients was significantly higher than that of B-mode ultrasonography. However, the sensitivity of CEUS needs to be improved further, and the combination of CEUS and AFP level may be a potential solution. 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  B-mode ultrasonography; Contrast-enhanced ultrasonography (CEUS); alpha fetoprotein (AFP); diagnostic accuracy; early hepatocellular carcinoma (early HCC)

Year:  2021        PMID: 34790401      PMCID: PMC8576229          DOI: 10.21037/jgo-21-611

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  25 in total

1.  Limited added value of contrast-enhanced ultrasound over B-mode for the subtyping of hepatocellular adenomas.

Authors:  Jules Gregory; Anita Paisant; Luisa Paulatto; Lucas Raynaud; Caroline Bertin; Anne Kerbaol; Marie-Pierre Vullierme; Valérie Paradis; Valérie Vilgrain; Maxime Ronot
Journal:  Eur J Radiol       Date:  2020-04-25       Impact factor: 3.528

2.  Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors.

Authors:  Lambros Tselikas; Frederic Pigneur; Marion Roux; Laurence Baranes; Charlotte Costentin; Vincent Roche; Julien Calderaro; Edouard Herin; Alexis Laurent; Elie Zafrani; Daniel Azoulay; Ariane Mallat; Alain Rahmouni; Alain Luciani
Journal:  Abdom Radiol (NY)       Date:  2017-03

3.  The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1.

Authors:  C A Marschner; L Zhang; V Schwarze; W Völckers; M F Froelich; N von Münchhausen; M L Schnitzer; T Geyer; M P Fabritius; J Rübenthaler; D-A Clevert
Journal:  Clin Hemorheol Microcirc       Date:  2020       Impact factor: 2.375

4.  Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.

Authors:  Yibin Wang; Jintang Liao; Wenjun Qi; Lulu Xie; Yueyi Li
Journal:  Ultrasound Med Biol       Date:  2016-01-21       Impact factor: 2.998

5.  Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.

Authors:  Mingjie Yao; Jingmin Zhao; Fengmin Lu
Journal:  Oncotarget       Date:  2016-01-26

6.  Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.

Authors:  Vincent Schwarze; Constantin Marschner; Wiebke Völckers; Sergio Grosu; Giovanna Negrão de Figueiredo; Johannes Rübenthaler; Dirk-André Clevert
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Hai-Chun Zhang; Ting Zhu; Rong-Fei Hu; Long Wu
Journal:  Ultrasonography       Date:  2020-03-13

8.  Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  Jie Yang; Ya-Han Zhang; Jia-Wu Li; Ying-Yu Shi; Jia-Yan Huang; Yan Luo; Ji-Bin Liu; Qiang Lu
Journal:  World J Gastroenterol       Date:  2020-12-14       Impact factor: 5.742

9.  Comparison of Sonazoid contrast-enhanced ultrasound and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid MRI for the histological diagnosis of hepatocellular carcinoma.

Authors:  Feiqian Wang; Kazushi Numata; Masahiro Okada; Makoto Chuma; Hiromi Nihonmatsu; Satoshi Moriya; Akito Nozaki; Katsuaki Ogushi; Wen Luo; Litao Ruan; Masayuki Nakano; Masako Otani; Yoshiaki Inayama; Shin Maeda
Journal:  Quant Imaging Med Surg       Date:  2021-06

10.  Hepatocellular Carcinoma Automatic Diagnosis within CEUS and B-Mode Ultrasound Images Using Advanced Machine Learning Methods.

Authors:  Delia Mitrea; Radu Badea; Paulina Mitrea; Stelian Brad; Sergiu Nedevschi
Journal:  Sensors (Basel)       Date:  2021-03-21       Impact factor: 3.576

View more
  2 in total

1.  Diagnostic accuracy of contrast-enhanced ultrasound for microvascular invasion of hepatocellular carcinoma: A protocol for systematic review and meta-analysis.

Authors:  Yanli Chen; Haiyan Qiao; Zhaoan Lian; Chunlin Li; Yi Xiang
Journal:  Medicine (Baltimore)       Date:  2022-04-15       Impact factor: 1.817

2.  High-frame-rate contrast-enhanced ultrasound findings of liver metastasis of duodenal gastrointestinal stromal tumor: A case report and literature review.

Authors:  Jia-Hui Chen; Ying Huang
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.